Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $28.21M | $23.15M | +21.86% |
Cost of Revenue | $20.36M | $21.83M | -6.71% |
Operating Income | $-196.88M | $-151.58M | -29.89% |
Net Income | $-188.91M | $-142.05M | -32.99% |
EPS (Basic) | $-0.79 | $-0.71 | -11.27% |
EPS (Diluted) | $-0.79 | $-0.71 | -11.27% |
R&D Expense | $141.49M | $101.74M | +39.07% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $775.86M | $666.7M | +16.37% |
Current Assets | $522.38M | $431.02M | +21.20% |
Total Liabilities | $191.41M | $197.74M | -3.20% |
Current Liabilities | $86.08M | $113.96M | -24.46% |
Stockholders' Equity | $584.45M | $468.96M | +24.63% |
Cash & Equivalents | $474.34M | $405.87M | +16.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-184.52M | $-140.78M | -31.07% |
Investing Cash Flow | $-10.84M | $-7.39M | -46.56% |
Financing Cash Flow | $277.02M | $5.71M | +4752.32% |
D&A | $16.34M | $9.27M | +76.30% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -697.9% | -654.7% | -43.15% |
Net Margin | -669.6% | — | — |
ROE | -32.3% | — | — |
ROA | -24.3% | — | — |
Current Ratio | $6.068 | — | — |
Debt to Equity | $0.328 | — | — |
Other companies in Biotechnology